What is the recommended treatment for patients with noncardioembolic AIS?
For patients with noncardioembolic AIS, the use of antiplatelet agents rather than oral anticoagulation is recommended to reduce the risk of recurrent stroke and other cardiovascular events. Individual selection of antiplatelet agents should be based on patient risk factor profiles, cost, tolerance, relative known efficacy of the agents, and other clinical characteristics.